Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Bladder cancer 💬
[1] BRAF 💬 Dabrafenib 💬 Dabrafenib [1] 34 💬
2 Bladder cancer 💬
[1] BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib [1] 34 💬
3 Bladder cancer 💬
[2] BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
4 Bladder cancer 💬
[2] BRAF, RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
5 Bladder cancer 💬
[1] CDK4 💬 Abemaciclib 💬 Abemaciclib [1] 34 💬
6 Bladder cancer 💬
[1] EGFR 💬 Cetuximab 💬 Cetuximab [5] 34, 51, 86, 89, 331 💬
7 Bladder cancer 💬
[1] EGFR 💬 Erlotinib hydrochloride 💬 Erlotinib [2] 94, 160 💬
8 Bladder cancer 💬
[1] EGFR 💬 Erlotinib 💬 Erlotinib [2] 94, 160 💬
9 Bladder cancer 💬
[1] EGFR 💬 Gefitinib 💬 Gefitinib [1] 75 💬
10 Bladder cancer 💬
[1] EGFR 💬 Icotinib 💬 Icotinib [1] 34 💬
11 Bladder cancer 💬
[2] EGFR, ERBB2 💬 Afatinib 💬 Afatinib [1] 285 💬
12 Bladder cancer 💬
[2] EGFR, ERBB2 💬 Afatinib dimaleate 💬 Afatinib [1] 285 💬
13 Bladder cancer 💬
[2] EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib [3] 34, 74, 75 💬
14 Bladder cancer 💬
[2] EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib [3] 34, 74, 75 💬
15 Bladder cancer 💬
[2] EGFR, ERBB2 💬 Neratinib 💬 Neratinib [1] 34 💬
16 Bladder cancer 💬
[2] EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib [1] 34 💬
17 Bladder cancer 💬
[2] EGFR, ERBB2 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
18 Bladder cancer 💬
[1] FGFR3 💬 Catequentinib 💬 Anlotinib [1] 85 💬
19 Bladder cancer 💬
[1] FGFR3 💬 Infigratinib 💬 Infigratinib [1] 276 💬
20 Bladder cancer 💬
[1] FGFR3 💬 Infigratinib phosphate 💬 Infigratinib [1] 276 💬
21 Bladder cancer 💬
[1] FGFR3 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
22 Bladder cancer 💬
[1] FGFR3 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
23 Bladder cancer 💬
[1] FGFR3 💬 Recifercept 💬 Recifercept [1] 276 💬
24 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib [1] 34 💬
25 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 Cobimetinib 💬 Cobimetinib [1] 280 💬
26 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 Cobimetinib fumarate 💬 Cobimetinib [1] 280 💬
27 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib [4] 34, 278, 279, 280 💬
28 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib [1] 34 💬
29 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib [1] 34 💬
30 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib [6]  2 , 34, 58, 195, 279, 280 💬
31 Bladder cancer 💬
[2] MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib [6]  2 , 34, 58, 195, 279, 280 💬
32 Bladder cancer 💬
[1] MMP9 💬 Andecaliximab 💬 Andecaliximab [5] 46, 96, 97, 272, 299 💬
33 Bladder cancer 💬
[1] SRC 💬 Bosutinib 💬 Bosutinib [2]  2 , 67 💬
34 Bladder cancer 💬
[1] SRC 💬 Bosutinib hydrate 💬 Bosutinib [2]  2 , 67 💬
35 Bladder cancer 💬
[1] SRC 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
36 Bladder cancer 💬
[1] SRC 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
37 Bladder cancer 💬
[1] SRC 💬 Saracatinib 💬 Saracatinib [3]  6 , 89, 272 💬
38 Bladder cancer 💬
[1] VEGFA 💬 Aflibercept 💬 Aflibercept [2] 90, 166 💬
39 Bladder cancer 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [8] 13, 34, 85, 87, 89, 227, 280, 331 💬
40 Bladder cancer 💬
[1] VEGFA 💬 Ranibizumab 💬 Ranibizumab [4] 34, 166, 227, 301 💬